The US Pain Foundation Launches New Awareness Initiative
Project aims to raise awareness for pain research.
In an effort to educate the public about pain research and its impact on over 51.6 million Americans living with chronic pain, the US Pain Foundation has started an initiative to highlight the need for more research to improve outcomes. Titled #PainTrials, the endeavor will focus on current pain research efforts — including those being conducted through the National Institutes of Health's Helping to End Addiction Long-term® (HEAL) initiative.
According to a company press release, the organization hopes to:
- Increase awareness that chronic pain is a disease in and of itself that must be addressed and properly treated.
- Spotlight the need for more pain research and emphasize the ways in which research promotes greater understanding of chronic pain and, subsequently, improved health outcomes.
- Highlight current pain research efforts, such as those being completed by the NIH HEAL Initiative and the Acute to Chronic Pain Signatures (A2CPS) Program.
- Inform individuals living with pain about the various types of pain research and how they contribute to the landscape of chronic pain treatment.
- Offer practical information for patients about how they can get involved with clinical trials, the questions they should be asking, and why participation in research is important.
"This month, we are excited to delve into the importance of pain research, and the impact research has on improved health outcomes for the millions of Americans living with the daily challenges of chronic pain," said Nicole Hemmenway, CEO, the US Pain Foundation. "We are excited to collaborate with the NIH HEAL Initiative, prominent researchers, and Humana to share the importance of pain research. A greater focus on research is vital to increase understanding and action surrounding chronic pain."
Reference: #PainTrials Initiative Seeks To Raise Awareness About The Need For Pain Research. PR Newswire. September 1, 2023. Accessed September 8, 2023. https://www.prnewswire.com/news-releases/paintrials-initiative-seeks-to-raise-awareness-about-the-need-for-pain-research-301914228.html
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
